Autoantibodies to the
MRI autoantibodies
NMDAr antibodies
adolescence
early onset psychosis
psychosis
Journal
Frontiers in psychiatry
ISSN: 1664-0640
Titre abrégé: Front Psychiatry
Pays: Switzerland
ID NLM: 101545006
Informations de publication
Date de publication:
2020
2020
Historique:
received:
28
04
2020
accepted:
26
06
2020
entrez:
9
8
2020
pubmed:
9
8
2020
medline:
9
8
2020
Statut:
epublish
Résumé
Autoantibodies to the Plasma samples were acquired from 46 adolescent EOP patients and 69 age- and sex matched HC, and assessed for the presence of immunoglobulin G NMDAR-Abs. All participants underwent psychiatric evaluation, neurological examination and head magnetic resonance imaging. NMDAR-Abs were detected in three of 46 (6.5%) EOP patients and in two of 69 (2.9%) HC. One NMDAR-Abs EOP patient presented with unusual psychopathology and minor T1 weighted lesions of vasculopathological origin located bi-frontally and in the basal ganglia, and had a recent diagnosis of a separate autoimmune disease. One NMDAR-Ab HC displayed a T2 weighted FLAIR hyperintensity lesion in the left frontal lobe. The remaining three NMDAR-Ab participants were two EOP patients without neurological or radiological findings, and one HC without any clinical findings. We report that a small number of EOP patients and HC have NMDAR-Abs with a similar frequency in both groups. The presence of the antibodies was not associated with any distinctive clinical or radiological features. Detection of the antibodies had no diagnostic implication, and a positive NMDAR antibody test must be carefully interpreted and reviewed within the individual clinical context.
Sections du résumé
BACKGROUND
BACKGROUND
Autoantibodies to the
METHOD
METHODS
Plasma samples were acquired from 46 adolescent EOP patients and 69 age- and sex matched HC, and assessed for the presence of immunoglobulin G NMDAR-Abs. All participants underwent psychiatric evaluation, neurological examination and head magnetic resonance imaging.
RESULTS
RESULTS
NMDAR-Abs were detected in three of 46 (6.5%) EOP patients and in two of 69 (2.9%) HC. One NMDAR-Abs EOP patient presented with unusual psychopathology and minor T1 weighted lesions of vasculopathological origin located bi-frontally and in the basal ganglia, and had a recent diagnosis of a separate autoimmune disease. One NMDAR-Ab HC displayed a T2 weighted FLAIR hyperintensity lesion in the left frontal lobe. The remaining three NMDAR-Ab participants were two EOP patients without neurological or radiological findings, and one HC without any clinical findings.
CONCLUSIONS
CONCLUSIONS
We report that a small number of EOP patients and HC have NMDAR-Abs with a similar frequency in both groups. The presence of the antibodies was not associated with any distinctive clinical or radiological features. Detection of the antibodies had no diagnostic implication, and a positive NMDAR antibody test must be carefully interpreted and reviewed within the individual clinical context.
Identifiants
pubmed: 32765314
doi: 10.3389/fpsyt.2020.00666
pmc: PMC7381144
doi:
Types de publication
Journal Article
Langues
eng
Pagination
666Informations de copyright
Copyright © 2020 Engen, Wortinger, Jørgensen, Lundberg, Bohman, Smelror, Myhre, Jacobson, Vincent and Agartz.
Références
Ann Neurol. 2014 Jul;76(1):82-94
pubmed: 24853231
Int Rev Neurobiol. 2007;78:69-108
pubmed: 17349858
JAMA Neurol. 2013 Sep 1;70(9):1133-9
pubmed: 23877059
Mol Psychiatry. 2014 Jan;19(1):20-9
pubmed: 24166406
J Am Acad Child Adolesc Psychiatry. 1991 May;30(3):457-65
pubmed: 2055884
Schizophr Bull. 1987;13(2):261-76
pubmed: 3616518
Lancet Neurol. 2011 Jan;10(1):63-74
pubmed: 21163445
Biol Psychiatry. 2015 Mar 15;77(6):537-47
pubmed: 25168608
Arch Gen Psychiatry. 1983 Nov;40(11):1228-31
pubmed: 6639293
J Child Psychol Psychiatry. 1986 Jan;27(1):87-98
pubmed: 3949910
Schizophr Bull. 2013 Jul;39(4):815-9
pubmed: 22416264
Lancet Neurol. 2008 Dec;7(12):1091-8
pubmed: 18851928
Lancet Neurol. 2014 Feb;13(2):167-77
pubmed: 24360484
J Am Acad Child Adolesc Psychiatry. 1997 Jul;36(7):980-8
pubmed: 9204677
Schizophr Bull. 2008 Jan;34(1):15-7
pubmed: 18048380
Br J Psychiatry. 2007 Jan;190:18-26
pubmed: 17197652
Indian J Dermatol Venereol Leprol. 2003 Jul-Aug;69(4):298-9
pubmed: 17642919
Mol Psychiatry. 2014 Oct;19(10):1143-9
pubmed: 23999527
Arch Intern Med. 1996 Jul 8;156(13):1421-5
pubmed: 8678710
Psychol Med. 2014 Sep;44(12):2475-87
pubmed: 24330811
Acta Neurol Scand. 1995 Aug;92(2):151-6
pubmed: 7484064
Ann Neurol. 2014 Jul;76(1):108-19
pubmed: 24916964
Acta Pharmacol Toxicol (Copenh). 1963;20:140-4
pubmed: 14060771
Clin Biochem. 2017 Apr;50(6):354-355
pubmed: 27889566
J Microbiol Immunol Infect. 2011 Jun;44(3):222-8
pubmed: 21524618
Lancet. 2011 Jun 18;377(9783):2093-102
pubmed: 21652063
Arch Gen Psychiatry. 1994 Mar;51(3):199-214
pubmed: 8122957
Schizophr Bull. 2009 May;35(3):549-62
pubmed: 19325164
Clin Dev Immunol. 2006 Jun-Dec;13(2-4):185-95
pubmed: 17162361
J Child Adolesc Psychopharmacol. 2016 Jun;26(5):410-27
pubmed: 27136403